Orbital Variations of Biogenic CaCO3 and Opal Abundance in the Western and Central Equatorial Pacific Ocean During the Late Quaternary

Biogenic CaCO3 and opal abundances were measured in two piston cores (PC313 and PC5101) collected, respectively, along the equator in the western and central Pacific Ocean. The age model for core PC313, which extends to about 750 ka, was developed by comparing the oxygen isotope stratigraphy of planktonic foraminifera (N. dutetrei) to the SPECMAP stack. The age model for core PC5101, which extends to about 600 ka, was developed by stratigraphic correlation of CaCO3 contents to those in the well-dated core RC11-210 (Chuey et al. 1987). Both cores distinctly exhibited a series of CaCO3 and opal variations, which are mainly controlled by the orbital eccentricity cycle of about 100-kyr. The orbital-scale cyclic variations of CaCO3 and opal contents appear to be contrasting in both cores such that high CaCO3 and low opal contents occurred during the glacial periods. In contrast, during the interglacial periods, low CaCO3 and high opal contents occurred. Mostly remarkable is the distinct occurrence of a mid-Bruhnes event (MBE) at around 350 ka. The CaCO3 content was higher in core PC5101 than in core PC313 before the MBE, whereas biogenic opal abundance became higher in core PC5101 after the MBE. Such a characteristic discrepancy of biogenic (CaCO3 and opal) production, i.e., a succession of primary producers from coccolithophore to diatom, between cores PC313 and PC5101 may be attributed to the prevailing dominant hydrographic conditions (i.e., the South Equatorial Current), in the path of which both cores are located. The intensity of westward propagation might have been an important factor in contrasting biogenic production centering around the MBE

Crystallization and preliminary X-ray crystallographic studies of the ice-binding protein from the Antarctic yeast Leucosporidium sp. AY30. Corrigendum

A correction to the article by Park et al. [(2011). Acta Cryst. F67, 800–802]

Prevalence and Genetic Structures of Streptococcus pneumoniae Serotype 6D, South Korea

To determine prevalence and genetic structures of new serotype 6D strains of pneumococci, we examined isolates from diverse clinical specimens in South Korea during 1991–2008. Fourteen serotype 6D strains accounted for 10.4% of serogroup 6 pneumococci from blood, sputum, nasopharynx, and throat samples. Serotype 6D strains consisted of 3 sequence types

Association of Plasma Retinol-Binding Protein 4, Adiponectin, and High Molecular Weight Adiponectin with Insulin Resistance in Non-Diabetic Hypertensive Patients

∙The authors have no financial conflicts of interest. Purpose: The aim of this study was to determine whether retinol-binding protein 4 (RBP4), adiponectin and high molecular weight (HMW) adiponectin are associated with insulin resistance (IR) and metabolic parameters in non-diabetic hypertensive patients. Also, we sought to compare the predictive values of these adipocytokines for IR in non-diabetic hypertensive patients. Materials and Methods: Analyses of RBP4, adiponectin, and HMW adiponectin were performed on 308 non-diabetic hypertensives (148 males, age 58 ± 10 years, 189 non-metabolic syndrome and 119 metabolic syndrome). The homeostasis model assessment (HOMA) index for IR, lipid profiles, and anthropometric measure-ments were assessed. Results: There was no significant difference in RBP4 levels according to the presence of metabolic syndrome, although adiponectin and HMW adiponectin were significantly lower in metabolic syndrome. Correlation analysis of log RBP4 with IR and metabolic indices revealed that there was no significant correlation of RBP4 with wais

A Case of Focal Segmental Glomerulosclerosis Associated with Aplastic Anemia

The pathogenic mechanism of focal segmental glomerulosclerosis (FSGS) and aplastic anemia are associated with immunologic events which lead to glomerular cell injury or hematopoietic cell destruction. We present an extremely rare case of FSGS with aplastic anemia in a 30-yr-old woman. The laboratory examination show-ed hemoglobin 7.2 g/dL, white blood count of 4,200/µl, platelet count 70,900/µl. Proteinuria (2+, 3.6 g/day) and microscopic hematuria were detected in urinalysis. The diagnosis of FSGS and aplastic anemia were confirmed by renal and bone marrow biopsy. She was treated with immunosuppressive therapy of prednisone 60 mg/day orally for 8 weeks and cyclosporine A 15 mg/kg/day orally. She responded with gradually improving her clinical manifestation and increasing peripheral blood cell counts. Prednisone was maintained at the adequate doses with tapering after 8 weeks and cyclosporine was given to achieve trough serum levels of 100-200 ng/mL. At review ten month after diagnosis and initial therapy, the patient was feeling well and her blood cell counts increased to near normal (Hb 9.5 g/dL, Hct 32%, WBC 8,300/µl, platelet 123,000/µl) and renal function maintains stable with normal range proteinuria (0.25 g/day)

Biogenic CaCO3 and Opal Depositions and Their Latitudinal Comparison During the Past 600 ka in the Central Equatorial Pacific

The orbital-scale variations in biogenic CaCO3 and opal abundance in two piston cores collected in the central equatorial Pacific (core PC5101 from a southern site at _ and core PC5103 from a northern site at _ were compared to assess latitudinal differences. The correlation between the oxygen isotope stratigraphy of planktonic foraminifera (Globigerinoides sacculifer) of PC5103 with the LR04 stacks provides the age of PC5103 to be approximately 950 ka. The age of PC5103 was further refined by correlating the CaCO3 content with the well-dated core RC11-210. The age of PC5101 was also constrained by the same CaCO3 chronostratigraphic correlation with RC11-210, resulting in an age of approximately 650 ka. Distinct orbital-scale series of CaCO3 and opal variations appear to be parallel between the two cores during the past 600 ka, which are controlled mainly by eccentricity with an approximate periodicity of 100 ka. It is worth noting that the biogenic CaCO3 and opal deposition patterns in the two cores differ between interglacial and glacial periods. During interglacial periods the biogenic opal content is higher in the southern core than in the northern core, which corresponds with the present-day condition. In contrast the CaCO3 content is higher in the northern core, which is contradictory to the present-day northward decreasing CaCO3 deposition pattern from the Equator. The collection site of PC5101 is approximately 350 m deeper than that of PC5103, which significantly promotes CaCO3 dissolution and causes unexpectedly high CaCO3 content at the northern site in contrast to the biogenic opal content

Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma

IntroductionFavorable responses to the treatment including immune checkpoint inhibitors (ICIs) have been consistently reported in lung cancer with smoking history. As the tumor microenvironment (TME) may be involved in the treatment response to ICIs, we aimed to investigate the TME of lung cancer with different smoking status.MethodsLung adenocarcinoma (LUAD) tissue (Tu) and adjacent normal-appearing lung tissue (NL) from current and never smokers were investigated by single-cell RNA sequencing and immunofluorescence and immunohistochemical staining. The clinical implications of identified biomarkers were validated using open-source datasets.ResultsThe lungs of smokers had an increased proportion of innate immune cells in NL tissues, whereas Tu tissues had a lower proportion of these cells than those of non-smokers. Monocyte-derived macrophages (mono-Mc), CD163-LGMN macrophages, monocyte-derived dendritic cells (DCs), and plasmacytoid DCs (pDCs) were significantly enriched in smokers’ Tu. Among these clusters, pDCs, specifically enriched in the Tu of smokers. The expression of representative pDC markers, leukocyte immunoglobulin-like receptor A4 (LILRA4) and Toll-like receptor 9 (TLR9), was increased in the stromal cells of LUAD in patients with a smoking history. In an animal model of lung cancer, ionizing radiation induced robust TLR9 expressing immune cells in peritumoral area. Survival analysis using a TCGA-LUAD dataset indicated that patients overexpressing pDC markers exhibited superior clinical outcomes to age-, sex-, and smoking-matched control groups. Top 25% patients with high TLR9 expression exhibited significantly higher tumor mutational burden than that of low TLR9 expression group (bottom 25% patients) (5.81 mutations/Mb vs 4.36 mutations/Mb; P = 0.0059, Welch’s two-sample t-test).ConclusionThere is an increased pDC in the TME of smokers’ lung cancer, and the response of pDC to DNA damaging treatment would lead a conducive environment to ICIs containing regimens. These findings suggest that R&D that induces an increase in the activated pDC population is continuously required to enhance therapeutic effectiveness of ICIs-containing therapies in lung cancer

Successful Treatment of Small-Cell Lung Cancer With Irinotecan in a Hemodialysis Patient With End-Stage Renal Disease

The prognosis of patients with end-stage renal disease has improved with advances in hemodialysis techniques. However, many patients who undergo hemodialysis suffer from various types of cancer. Limited data is available to guide clinical management of these patients who may have impaired renal function. Here, we report our experience with the use of irinotecan for the treatment of a hemodialysis patient with small-cell lung cancer and end-stage renal disease